Cat allergy vax looks promising; Philip Morris buys stake in Medicago; Nobel Prize-winner dies;

Vaccine Research

Although allergy shots have been available for years, scientists may have found an alternative treatment requiring far fewer shots. A clinical trial that Adiga Life Sciences' cat allergy vaccine showed no serious side effects and reduced allergic reactions by 40 percent. Story

According to results presented at the International Liver Congress, the first hepatitis C vaccine could be on its way. Phase I testing showed that the T-cell vaccine had strong immunogenicity without liver immunopathology. Release

Vaccine Market

Philip Morris has purchased a minority stake in Medicago for $9 million. Medicago uses tobacco leaves to create various influenza vaccines. News

Baruch Blumberg, a Nobel Prize-winner and discoverer of the hepatitis B vaccine, died this week at the age of 85. More than 1 billion doses of hepatitis B vaccines have been distributed since they became commercially available in 1982. Article

The editors of R&D Directions magazine have named Novavax's VLP influenza vaccine one of the top "100 great investigational drugs in development." Novavax release

A physician in Orleans County, NY, has admitted he received $80,000 in insurance payments for free children's vaccines. Dr. Ghulam Mustafa will be sentenced Aug. 5 for making false statements in a healthcare matter, a felony. Report

Two of the Democratic Republic of Congo's 11 provinces will begin distributing pneumoccocal vaccine doses as part of the Global Alliance for Vaccines and Immunization's expanded vax program. Report

Suggested Articles

Daiichi Sankyo says it still unable to fulfill a government mandate to be able to produce enough H5N1 flu vaccine to fight an epidemic in Japan.

GSK’s Shingrix has continuously impressed industry watchers with its growth, and the company just added another large market to its list: China.

WuXi Biologics says it will build a dedicated facility to manufacture a commercial vaccine product for a client in a $3 billion contract.